By Focus
An Outlook on 2026 AI IPOs
A Historic Reopening of the IPO Window After a long period of subpar issuance, the U.S. IPO market is staging a strong comeback in 2026,…
The Investor Standard – Your Investing Edge
Receive curated weekly stock picks, top-performing equities, and actionable investment ideas to maximise your portfolio potential.
Investor Insights, Delivered
Unlock expert insights, stock recommendations, and market analysis – all in one place. Get the latest market news and stock picks instantly.
Further Analysis & Commentary
An Outlook on Private Credit
Private credit, which involves lending by non-bank institutions, has grown rapidly in recent years as borrowers seek flexible financing solutions.…
Elon Musk’s Great Reshuffle, Robots, Mega Mergers and What Comes After Tesla’s Flagship Cars
A Fortnight That Redefined Tesla Late January marked a clear inflection point for Tesla’s identity. The company confirmed it will…
Investment Analysis: Mesoblast Ltd (ASX: MSB)
Business Summary Mesoblast Limited specializes in developing allogeneic, “off‑the‑shelf” cellular medicines designed to treat severe inflammatory conditions. The company’s late‑stage…
AI funding landscape 2026
Anthropic’s $20B Mega Raise, Has the AI Funding Crown Changed Hands? Anthropic has reportedly doubled its latest funding target to…
Socials
Monthly Investor Memo
Delivered Monthly - 2026